We observed potent, combinatorial inhibition of spheroid growth by PRT1419 and Belzutifan in PBRM1 mutant, VHL-null ccRCC cell line KRMC-2 (Figure 3D). The gene discussed is PBRM1; the disease is nonpapillary renal cell carcinoma.